 Home > Popular Keywords > Keyword List A > antiangiogenic therapy

antiangiogenic therapy

Echemi provide antiangiogenic therapy related news articles. You'll find the trends and top topics of antiangiogenic therapy here.

Transl Lung Cancer Res: Efficacy of chemotherapy-antiangiogenic versus chemotherapy-immunotherapy

 Time of Update: 2022-03-04

We screened patients with advanced NSCLC with EGFR mutations diagnosed between January 2015 and December 2020, who received chemotherapy-antiangiogenic or chemotherapy-immunotherapy combination therapy after EGFR-TKI resistance .
The Chinese Expert Consensus on Antiangiogenic Drug Therapy for Advanced Non-Small Cell Lung Cancer

 Time of Update: 2020-10-04

the new edition of Consensus further affirms the indispensable position of anti-angiogenesic drugs in the treatment of advanced non-small cell lung cancer (NSCLC), points out the development direction for late NSCLC treatment, and also provides theoretical reference for more primary hospital doctors, as well as professional interpretation of the guidelines recommended to help improve the overall level of lung cancer treatment in China.
Study on GBM for non-viral delivery therapy of antiangiogenic factors

 Time of Update: 2020-06-02

Anne Clavreul of neurosurgery at the University of Ange in France uses non-viral methods such as enhanced delivery devices (CED devices), implantable polymer devices, nanocarriers or cell vectors to enable angiogenesis inhibitors to perform anti-tumor angiogenesis in intracranial insinuate GBM animal models The findings were published in the April 2019 Issue of International Journal of Nanomedicine - From the article Ref: Clavreul A , et al.

Hot Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

What's trending

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.